Serial prolactin sampling as a confirmatory test for true hyperprolactinemia.

Autor: Francés C; Endocrinology and Nutrition, Internal Medicine Department, University General Hospital of Elche, Elche, Spain. Electronic address: cfrancesartigas@gmail.com., Boix E; Endocrinology and Nutrition, Internal Medicine Department, University General Hospital of Elche, Elche, Spain; Miguel Hernández University of Elche, Elche, Spain., Fajardo MT; Laboratory Department, University General Hospital of Elche, Elche, Spain., Gómez-García JM; Preventive Medicine Department, University General Hospital of Elche, Elche, Spain.
Jazyk: English; Spanish; Castilian
Zdroj: Endocrinologia, diabetes y nutricion [Endocrinol Diabetes Nutr (Engl Ed)] 2020 Oct; Vol. 67 (8), pp. 525-529. Date of Electronic Publication: 2020 Feb 26.
DOI: 10.1016/j.endinu.2019.11.006
Abstrakt: Introduction: Hyperprolactinemia may be due to physiological or pathological causes, and may be asymptomatic or induce hypogonadism, infertility, and/or galactorrhea. It is important to take prolactin samples while avoiding stress, as this may increase prolactin levels. Therefore, our aim was to assess the value of prolactin serial sampling after brachial vein cannulation.
Patients and Methods: Sixty-six patients (34.9±11.8 years of age, 92.4% female) with an initial elevated random prolactin level were included. A prolactin sample was drawn at baseline and after a 30min rest.
Results: The median referral prolactin level was 37.4ng/ml (interquartile range [IQR* 23.3), the baseline prolactin level at serial sampling was 19.5ng/ml (IQR 8), and the value after a 30min rest was 17.1ng/ml (IQR 7.9). Hyperprolactinemia was not confirmed by serial sampling in 45 patients (68.2%). There were no statistically significant differences in referral prolactin levels between patients with and without confirmed hyperprolactinemia (41.2ng/ml and 36.7ng/ml respectively, p=0.3). Galactorrhea was found in 13.6% of patients, amenorrhea or oligomenorrhea in 28.8%, infertility in 7.6%, erectile dysfunction in 4.6%, and gynecomastia in 3%, while 45.5% were asymptomatic. There were no statistical differences regarding the presence or absence of any of these symptoms and subsequent confirmed hyperprolactinemia. Fifty-seven patients (86.4%) were discharged after the results of the prolactin serial sampling were obtained.
Conclusions: Prolactin serial sampling may be a useful test to detect artefactual hyperprolactinemias, thus avoiding unnecessary additional tests and treatments.
(Copyright © 2020 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: